Serum IL-33 Is Elevated in Children with Asthma and Is Associated with Disease Severity

Author(s): 
Bahrami Mahneh S1
Movahedi M
Aryan Z
Bahar MA
Rezaei A
Sadr M
Rezaei N; Universal Scientific Education and Research Network (USERN)
Abstract: 

BACKGROUND:

The role of IL-33, a member of the IL-1 family, in airway hyperresponsiveness and asthma has still to be fully understood.

OBJECTIVES:

This study is aimed at investigating serum IL-33 in children with asthma and its association with asthma severity.

METHODS:

This age- and sex-matched case-control study comprised 61 children with asthma and 63 healthy controls. The mean age of the participants was 9.21 years (range: 6-14). Serum IL-33 was measured using ELISA and was compared between children withasthma and controls. In addition, the association of serum IL-33 with asthma severity was investigated.

RESULTS:

The level of serum IL-33 was significantly higher in children with asthma than in controls (15.17 ± 32.3 vs. 0.61 ± 2.16 pg/ml; p = 0.028). It was significantly increased proportionately to asthma severity, namely 9.92 ± 30.26 pg/ml in children with mildasthma, 13.68 ± 29.27 pg/ml in children with moderate asthma and 31.92 ± 41.45 pg/ml in children with severe asthma (p = 0.026).

CONCLUSION:

Serum IL-33 is increased in children with asthma and is associated with disease severity.

URL: 
https://www.ncbi.nlm.nih.gov/pubmed/?term=Serum+IL-33+Is+Elevated+in+Children+with+Asthma+and+Is+Associated+with+Disease+Severity

Contact Us

Research Center for Immunodeficiencies

Address: Pediatrics Center of Excellence, Children’s Medical Center Hospital, 62 Qarib St., Keshavarz Blvd., Tehran 14194, Iran

Research Center For immunodeficiency

Research Center For immunodeficiency